The role of regulatory flexibility in the review and approval process of rare disease drug development

Shein-Chung Chow, Anne Pariser, Steven Galson

Open source

DOI: 10.1080/10543406.2025.2489290
Published: 2025-04-11
Container: Journal of Biopharmaceutical Statistics
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/10543406.2025.2489290,
  title = {The role of regulatory flexibility in the review and approval process of rare disease drug development},
  author = {Shein-Chung Chow and Anne Pariser and Steven Galson},
  year = {2025},
  journal = {Journal of Biopharmaceutical Statistics},
  doi = {10.1080/10543406.2025.2489290},
  url = {https://doi.org/10.1080/10543406.2025.2489290}
}

RIS

TY  - JOUR
TI  - The role of regulatory flexibility in the review and approval process of rare disease drug development
AU  - Shein-Chung Chow
AU  - Anne Pariser
AU  - Steven Galson
PY  - 2025
JO  - Journal of Biopharmaceutical Statistics
DO  - 10.1080/10543406.2025.2489290
UR  - https://doi.org/10.1080/10543406.2025.2489290
ER  -

APA

Chow, S., Pariser, A., & Galson, S. (2025). The role of regulatory flexibility in the review and approval process of rare disease drug development. Journal of Biopharmaceutical Statistics. https://doi.org/10.1080/10543406.2025.2489290

Source records

crossref · retrieved 2026-09-26T15:00:38.503Z